Evidence map›Paper›PMID 39973474›Full record

ReviewFEBS letters2025

Immunoregulatory mechanisms of the arachidonic acid pathway in cancer.

Maria Tredicine, Matteo Mucci, Antonio Recchiuti, Domenico Mattoscio

Abstract readReview
In one paragraph

Review in FEBS letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Single-cell and spatial transcriptomics reveal an arachidonic acid-related cellular atlas in lung adenocarcinoma.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Targeting the Vim-PGIHuman mutation · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Broadband Collision-Induced Dissociation Mass Spectrometry Imaging.Journal of the American Society for Mass Spectrometry · 2025
    Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Maria TredicineDepartment of Medical, Oral and Biotechnological Sciences, University of Chieti-Pescara, Italy.
Matteo MucciDepartment of Medical, Oral and Biotechnological Sciences, University of Chieti-Pescara, Italy.
Antonio RecchiutiDepartment of Medical, Oral and Biotechnological Sciences, University of Chieti-Pescara, Italy.
Domenico MattoscioDepartment of Medical, Oral and Biotechnological Sciences, University of Chieti-Pescara, Italy.ORCID https://orcid.org/0000-0002-2149-2855

Funding

Associazione Italiana per la Ricerca sul Cancro 27060Cystic Fibrosis Foundation MATTOSC24IO
6 · The paper itself

Abstract

The arachidonic acid (AA) pathway promotes tumor progression by modulating the complex interactions between cancer and immune cells within the microenvironment. In this Review, we summarize the knowledge acquired thus far concerning the intricate mechanisms through which eicosanoids either promote or suppress the antitumor immune response. In addition, we will discuss the impact of eicosanoids on immune cells and how they affect responsiveness to immunotherapy, as well as potential strategies for manipulating the AA pathway to improve anticancer immunotherapy. Understanding the molecular pathways and mechanisms underlying the role played by AA and its metabolites in tumor progression may contribute to the development of more effective anticancer immunotherapies.

Indexed as

Arachidonic AcidNeoplasmsAnimalsEicosanoidsHumansImmunotherapySignal TransductionTumor MicroenvironmentArachidonic AcidEicosanoidsarachidonic acidcancercyclooxygenaseseicosanoidsimmunityimmunotherapyleukotrieneslipoxygenasespro‐resolving mediatorsprostaglandins

Identifiers

PMID39973474
PMCPMC11995684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.